LOPEZ FAWN D 4

What Happened Fawn D. Lopez, a director of Community Health Systems, was granted 52,023 restricted stock units (RSUs) on March 1, 2026. The RSUs were reported as a derivative award with an acquisition price of $0.00 (i.e., a compensation grant rather than a cash purchase). No immediate cash value was exchanged at grant; the economic value will depend on the company’s share price when the RSUs vest and are settled.

Key Details

• Transaction date: 2026-03-01; Form 4 filed: 2026-03-03 (appears timely under the two-business-day rule).
• Award: 52,023 RSUs recorded as a derivative acquisition at $0.00 per unit.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnotes:
  • F1: RSUs vest in 1/3 increments on each of the first, second and third anniversaries of the grant and, upon vesting, are settled one-for-one into common shares.
  • F2: Similar 1/3 annual vesting; based on the reporting person’s prior deferral elections, settlement will occur one-for-one into shares upon the director’s cessation or on previously specified dates.
• Transaction code: A = Award/Grant.

Context This was a compensation grant (RSUs), not an open-market purchase or sale. RSUs typically reflect compensation and retention incentives and do not by themselves signal an immediate buy or sell decision—realized value depends on future vesting and the stock price at settlement.